Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells.

作者: Artur Beberok , Dorota Wrześniok , Aldona Minecka , Jakub Rok , Marcin Delijewski

DOI: 10.1016/J.PHAREP.2017.07.007

关键词:

摘要: Abstract Background Low effectiveness of anti-melanoma therapies makes it necessary to search for new drugs that could improve or replace the standard chemotherapy. Fluoroquinolones are a group synthetic antibiotics, used in treatment wide range bacterial infections. Moreover, this class antibiotics has shown promising anti-tumor activity several cancer cell lines. The aim study was examine effect ciprofloxacin on viability, apoptosis and cycle distribution COLO829 melanoma cells. Methods Cell viability evaluated by WST-1 assay. cells exposed analyzed use fluorescence image cytometer NucleoCounter NC-3000. Results Ciprofloxacin decreased dose- time-dependent manner. For treated with 24 h, 48 h 72 h values IC50 were found be 0.74 mM, 0.17 mM 0.10 mM, respectively. oligonucleosomal DNA fragmentation observed when concentration 1.0 mM 72 h. At lower concentrations (0.01 mM 0.1 mM) arrested S-phase suggesting mechanism related topoisomerase II inhibition. demonstrated induced as result mitochondrial membrane breakdown. Conclusions obtained results compared data normal dark pigmented melanocytes potential anticancer drug vivo considered.

参考文章(42)
Tomasz Drewa, Tomasz Kloskowski, Romana Joachimiak, Monika Nowak, Natalia Gurtowska, Joanna Olkowska, Anna Bajek, The influence of ciprofloxacin on viability of A549, HepG2, A375.S2, B16 and C6 cell lines in vitro. Acta Poloniae Pharmaceutica. ,vol. 68, pp. 859- 865 ,(2011)
Vikram C. Gorantla, John M. Kirkwood, State of Melanoma: An Historic Overview of a Field in Transition Hematology-oncology Clinics of North America. ,vol. 28, pp. 415- 435 ,(2014) , 10.1016/J.HOC.2014.02.010
M G Bergeron, The pharmacokinetics and tissue penetration of the fluoroquinolones. Clinical and Investigative Medicine. ,vol. 12, pp. 20- 27 ,(1989)
Allen W. Ho, Hensin Tsao, Targeted Therapies in Melanoma: Translational Research at Its Finest. Journal of Investigative Dermatology. ,vol. 135, pp. 1929- 1933 ,(2015) , 10.1038/JID.2015.14
Fazlul H. Sarkar, David P. Wood, Olivia Aranha, Ciprofloxacin Mediated Cell Growth Inhibition, S/G2-M Cell Cycle Arrest, and Apoptosis in a Human Transitional Cell Carcinoma of the Bladder Cell Line Clinical Cancer Research. ,vol. 6, pp. 891- 900 ,(2000)
Vikas Yadav, Pallavi Varshney, Sarwat Sultana, Jyoti Yadav, Neeru Saini, Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation BMC Cancer. ,vol. 15, pp. 581- 581 ,(2015) , 10.1186/S12885-015-1560-Y
Vikas Yadav, Sarwat Sultana, Jyoti Yadav, Neeru Saini, Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53. PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0047796
TOMASZ KLOSKOWSKI, NATALIA GURTOWSKA, JOANNA OLKOWSKA, JAKUB MARCIN NOWAK, JAN ADAMOWICZ, JAKUB TWORKIEWICZ, ROBERT DĘBSKI, ALINA GRZANKA, TOMASZ DREWA, Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC International Journal of Oncology. ,vol. 41, pp. 1943- 1949 ,(2012) , 10.3892/IJO.2012.1653
Artur Beberok, Ewa Buszman, Dorota Wrześniok, Michał Otręba, Janina Trzcionka, Interaction between ciprofloxacin and melanin: The effect on proliferation and melanization in melanocytes European Journal of Pharmacology. ,vol. 669, pp. 32- 37 ,(2011) , 10.1016/J.EJPHAR.2011.08.003